ADVB (Advanced Biomed Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Advanced Biomed Inc. Common Stock (ADVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ADVB trades at $4.36 with a market cap of $7.47M and a P/E ratio of -28.16. ADVB moved +0.00% today. Year to date, ADVB is -34.05%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.61 to $82.00. Rallies surfaces ADVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ADVB stock?

Rallies tracks hedge fund and 13F ownership for ADVB, including fund holders, share counts, and position changes when data is available.

ADVB Key Metrics

Key financial metrics for ADVB
MetricValue
Price$4.36
Market Cap$7.47M
P/E Ratio-28.16
EPS$-0.16
Dividend Yield0.00%
52-Week High$82.00
52-Week Low$3.61
Volume516
Avg Volume0
Revenue (TTM)$0
Net Income$-3.26M
Gross Margin0.00%

Latest ADVB News

ADVB Analyst Consensus

ADVB analyst coverage data. Average price target: $0.00.

Common questions about ADVB

Who owns ADVB stock?
Rallies tracks hedge fund and 13F ownership for ADVB, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for ADVB?
Yes. Rallies tracks hedge fund and 13F ownership data for ADVB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ADVB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ADVB. It does not provide personalized investment advice.
ADVB

ADVB